Advertisement

Topics

Search Results for "Dabur Sanat Pharma"

11:10 EDT 28th June 2016 | BioPortfolio

Matching Channels

Datamonitor - aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapidly evolving marketplace

The Datamonitor Group aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapi...

Laboratory

Labs are the hub of much of modern medicine, either in the hospital setting processing patients blood tests and other samples, in research institutions at many universities or in the headquarters of...

OxyContin

OxyContin, an narcotic <!--LGfEGNT2Lhm-->analgesic produced by Purdue Pharma LP, nets $3m in <!--LGfEGNT2Lhm-->sales annually, placing it 8th in the world for annual sales. OxyContin i...

Eligard

Eligard® is a hormone compound for the treatment of advanced, hormone-dependent prostate cancer. The active ingredient (leuprolide acetate) significantly reduces the level of the male sex hormon...

Zyme Communications

Zyme Communications provides PR and marketing services for the life science sector. We support companies to raise their profile, build corporate value, and generate interest from commercial leads...

Matching News

Merck appoints Sanat Chattopadhyay as VP, President

Biospectrum Merck has appointed Sanat Chattopadhyay as executive vice president and president, Merck Manufacturing Divi...

Sanat Chattopadhyay named as president of Merck Manufacturing Division

Merck names new manufacturing head, replacing 12-year veteran

Sanat Chattopadhyay has more than 30 years of pharmaceutical experience and has been at Merck since 2009.

HealthCare at Home India to invest Rs. 100 cr for pan─India expansion, team strength to upto 1,000

HealthCare at Home (HCH) India, a joint venture between the Burman family, the promoters of Dabur Group and founders of Health Care At Home, UK is slating a Rs. 100 crore investment for its pan─Indi...

BRIEF-UK's CMA says not to refer Leo Pharma deal to buy Astellas Pharma portfolio to investigation

* Decided not to refer anticipated acquisition by Leo Pharma of the portfolio of pharma dermatological products of Astellas Pharma to phase 2 investigation Source text for Eikon: Further company cover...

Kiadis Pharma Appoints PCT as its Contract Manufacturing Organization in the United States

~ PCT will supply study medication for the US part of Kiadis Pharma's Phase III clinical trial with ATIR101™ ~ Regulatory News: Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amst.....

Moberg Pharma Divests Three Brands for $10.0 Million

Regulatory News: Moberg Pharma (STO:MOB) Moberg Pharma AB (OMX: MOB) announces that the company has entered into an agreement with Strides Pharma Inc. to divest the brands Jointflex, Fergon and Va...

Celtic Pharma: Attracting Big Pharma with experience and raising US$ 750M

In this interview, filmed at PharmaTelevision’s Oxford Studios, Dr Fintan Walton speaks with Stephen Parker, Partner at Celtic Pharma, a source of private equity and venture capital created in 2004....

Matching PubMed Articles

Digital health revolution: Perfect storm or perfect opportunity for pharmaceutical R&D?

The convergence of technology and medicine has pushed healthcare to the brink of a major disruption that pharma has, until recently, been slow to recognize. Tech players have pioneered the emerging fi...

Pharma Success in Product Development-Does Biotechnology Change the Paradigm in Product Development and Attrition.

The biotechnology segment of the overall biopharma industry has existed for only about 40-45 years, as a driver of new product development. This driving force was initiated with the FDA approval of r...

Management of osteoarthritis (OA) with the pharma-standard supplement FlexiQule (Boswellia): a 12-week registry.

This registry study assessed the pharma-standard supplement FlexiQule (Boswellia extract in capsules) in the management of symptoms associated to osteoarthritis (OA) also managed with the 'standard ma...

Hepatoprotective activity of a new polyherbal formulation against paracetamol and D-galactosamine induced hepatic toxicity.

The present study was envisaged to evaluate the protective effect of polyherbal formulation, DRDC/AY/8060, developed by Dabur India Ltd., against paracetamol and D-galactosamine induced hepatic toxici...

Pharma Exposure Occurs Early in Training and More Often in Rural Clinical Sites.

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement